Trials / Recruiting
RecruitingNCT07073287
Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients
Efficacy of Cerebello-spinal Direct Current Stimulation on Functional Mobility in Chronic Stroke Patients
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Universidade Federal de Pernambuco · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical trial is to determine if cerebello-spinal direct current stimulation (csDCS) is effective in treating gait disorders in individuals with chronic stroke. Additionally, the trial seeks to evaluate the safety of this technique. The primary objectives include: Investigating whether cerebello-spinal direct current stimulation improves gait and functional mobility in participants with chronic stroke. Assessing any potential side effects associated with the method. Researchers will conduct a comparative analysis between cerebello-spinal direct current stimulation and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness in addressing gait disorders and enhancing mobility. Participants in the trial will: Undergo cerebello-spinal direct current stimulation combined with treadmill training or a sham procedure with treadmill training daily over a two-week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cerebello-spinal direct current stimulation | csDCS influences both ascending and descending spinal pathways and reflex excitability, promoting prolonged functional neuroplastic changes. |
| DEVICE | Sham Comparator | Masking for cerebello-spinal direct current stimulation involves the electric current stopping after 30 seconds, providing a sensation without producing neuromodulation. |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2026-01-01
- Completion
- 2026-08-01
- First posted
- 2025-07-18
- Last updated
- 2025-07-18
Locations
3 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07073287. Inclusion in this directory is not an endorsement.